{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:00:23Z","timestamp":1787022023950,"version":"build-2736575974"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T00:00:00Z","timestamp":1523232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS060115"],"award-info":[{"award-number":["NS060115"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA092584"],"award-info":[{"award-number":["CA092584"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG04337601"],"award-info":[{"award-number":["AG04337601"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0194580","type":"journal-article","created":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T13:30:20Z","timestamp":1523280620000},"page":"e0194580","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["XJB-5-131-mediated improvement in physiology and behaviour of the R6\/2 mouse model of Huntington's disease is age- and sex- dependent"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9542-5807","authenticated-orcid":true,"given":"Aris A.","family":"Polyzos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel I.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Wipf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Jennifer","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4824-6371","authenticated-orcid":true,"given":"Cynthia T.","family":"McMurray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,4,9]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.21873\/invivo.11022","article-title":"Effectiveness of analogs of the GS-nitroxide, JP4-039, as total body irradiation mitigators","volume":"31","author":"MW Epperly","year":"2017","journal-title":"In Vivo"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.yjmcc.2014.10.009","article-title":"Mitochondria-targeted ROS scavenger improves post-ischemic recovery of cardiac function and attenuates mitochondrial abnormalities in aged rats","volume":"77","author":"N Escobales","year":"2014","journal-title":"J Mol Cell Cardiol"},{"issue":"37","key":"ref3","doi-asserted-by":"crossref","first-page":"39469","DOI":"10.18632\/oncotarget.5783","article-title":"Mitochondria-targeted antioxidant preserves contractile properties and mitochondrial function of skeletal muscle in aged rats","volume":"6","author":"S Javadov","year":"2015","journal-title":"Oncotarget"},{"issue":"9","key":"ref4","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1021\/acscentsci.6b00199","article-title":"A mitochondrial-targeted nitroxide Is a potent inhibitor of ferroptosis","volume":"2","author":"T Krainz","year":"2016","journal-title":"ACS Cent Sci"},{"issue":"14","key":"ref5","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.addr.2009.06.008","article-title":"Mitochondrial targeting of electron scavenging antioxidants: Regulation of selective oxidation vs random chain reactions","volume":"61","author":"VE Kagan","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/nn.3195","article-title":"Lipidomics identifies cardiolipin oxidation as a mitochondrial target for redox therapy of brain injury","volume":"15","author":"J Ji","year":"2012","journal-title":"Nat. Neurosci"},{"issue":"7","key":"ref7","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/jor.22320","article-title":"Mitochondrial-derived reactive oxygen species (ROS) play a causal role in aging-related intervertebral disc degeneration","volume":"31","author":"LA Nasto","year":"2013","journal-title":"J Orthop Res"},{"issue":"9","key":"ref8","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1093\/hmg\/ddw051","article-title":"Mitochondrial targeting of XJB-5-131 attenuates or improves pathophysiology in HdhQ150 animals with well-developed disease phenotypes","volume":"25","author":"A Polyzos","year":"2016","journal-title":"Hum Mol Gen"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.celrep.2012.10.001","article-title":"Targeting of XJB-5-131 to mitochondria suppresses oxidative DNA damage and motor decline in a mouse model of Huntington&apos;s disease","volume":"29","author":"Z Xun","year":"2012","journal-title":"Cell Rep"},{"issue":"8","key":"ref10","doi-asserted-by":"crossref","first-page":"e1005267","DOI":"10.1371\/journal.pgen.1005267","article-title":"Suppression of somatic expansion delays motor decline in a mouse model of Huntington\u2019s disease","volume":"11","author":"H Budworth","year":"2016","journal-title":"PloS Genet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/hmg\/10.2.137","article-title":"Neurological abnormalities in a knock-in mouse model of Huntington&apos;s disease","volume":"10","author":"CH Lin","year":"2001","journal-title":"Hum Mol Genet"},{"issue":"24","key":"ref12","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1093\/hmg\/ddg352","article-title":"Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis","volume":"12","author":"L Kennedy","year":"2003","journal-title":"Hum Mol Genet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/hmg\/ddt406","article-title":"Loss of caveolin-1 expression in knock-in mouse model of Huntington&apos;s disease suppresses pathophysiology in vivo","volume":"23","author":"EV Trushina","year":"2014","journal-title":"Hum Mol Genet"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainresbull.2006.11.004","article-title":"The <italic>Hdh(Q150\/Q150)<\/italic> knock-in mouse model of HD and the <italic>R6\/2<\/italic> exon 1 model develop comparable and widespread molecular phenotypes","volume":"72","author":"B Woodman","year":"2007","journal-title":"Brain Res Bull"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.bcp.2007.05.019","article-title":"Hemigramicidin-TEMPO conjugates: novel mitochondria-targeted anti-oxidants","volume":"74","author":"MP Fink","year":"2007","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/nn.3222","article-title":"Knockout punch: cardiolipin oxidation in trauma","volume":"15","author":"RB Chan","year":"2012","journal-title":"Nat Neurosci"},{"issue":"8","key":"ref17","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","article-title":"Characterization of progressive motor deficits in mice transgenic for the human Huntington&apos;s disease mutation","volume":"19","author":"RJ Carter","year":"1999","journal-title":"J Neurosci"},{"issue":"23","key":"ref18","doi-asserted-by":"crossref","first-page":"10428","DOI":"10.1523\/JNEUROSCI.19-23-10428.1999","article-title":"Selective discrimination learning impairments in mice expressing the human Huntington&apos;s disease mutation","volume":"19","author":"LA Lione","year":"1999","journal-title":"J Neurosci"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the <italic>HD<\/italic> gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"L Mangiarini","year":"1996","journal-title":"Cell"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1023\/A:1010887421592","article-title":"Progressive formation of inclusions in the striatum and hippocampus of mice transgenic for the human Huntington&apos;s disease mutation","volume":"29","author":"AJ Morton","year":"2000","journal-title":"J Neurocytol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.nbd.2008.10.009","article-title":"CAG repeat lengths \u2265335 attenuate the phenotype in the <italic>R6\/2<\/italic> Huntington\u2019s disease transgenic mouse","volume":"33","author":"I Dragatsis","year":"2009","journal-title":"Neurobiol Dis"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/86906","article-title":"Trinucleotide expansion in haploid germ cells by gap repair","volume":"27","author":"IV Kovtun","year":"2001","journal-title":"Nat Genet"},{"issue":"24","key":"ref23","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1093\/hmg\/ddh325","article-title":"Somatic deletion events occur during early embryonic development and modify the extent of CAG expansion in subsequent generations","volume":"13","author":"I Kovtun","year":"2004","journal-title":"Hum Mol Gen"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.nbd.2015.01.004","article-title":"Age-, tissue- and length-dependent bidirectional somatic CAG\u2022CTG repeat instability in an allelic series of <italic>R6\/2<\/italic> Huntington disease mice","volume":"76","author":"E Larson","year":"2015","journal-title":"Neurobiol Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/ng0297-197","article-title":"Instability of highly expanded CAG repeats in mice transgenic for the Huntington&apos;s disease mutation","volume":"15","author":"L Mangiarini","year":"1997","journal-title":"Nat. Genet"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"e17119","DOI":"10.1371\/journal.pone.0017119","article-title":"Unusual structures are present in DNA fragments containing super-long Huntingtin CAG repeats","volume":"6","author":"D Duzdevich","year":"2011","journal-title":"PLoS One"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.nbd.2008.11.015","article-title":"Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in <italic>R6\/2<\/italic> mice","volume":"33","author":"AJ Morton","year":"2009","journal-title":"Neurobiol. Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s003359900551","article-title":"Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment","volume":"8","author":"DC Rogers","year":"1997","journal-title":"Mamm Genome"},{"issue":"19","key":"ref29","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1093\/hmg\/ddg249","article-title":"Complexin II is essential for normal neurological function in mice","volume":"12","author":"D Glynn","year":"2003","journal-title":"Hum Mol Genet"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1126\/science.1132191","article-title":"Transgenic mice with a reduced core body temperature have an increased life span","volume":"314","author":"B Conti","year":"2006","journal-title":"Science"},{"key":"ref31","article-title":"ImageJ","author":"WS Rasband","year":"1997"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s00221-005-2357-z","article-title":"Atypical diabetes associated with inclusion formation in the <italic>R6\/2<\/italic> mouse model of Huntington&apos;s disease is not improved by treatment with hypoglycaemic agents","volume":"166","author":"MJ Hunt","year":"2005","journal-title":"Exp Brain Res"},{"issue":"5","key":"ref33","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/hmg\/ddi053","article-title":"The <italic>R6\/2<\/italic> transgenic mouse model of Huntington&apos;s disease develops diabetes due to deficient beta-cell mass and exocytosis","volume":"14","author":"M Bj\u00f6rkqvist","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"2","key":"ref34","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.expneurol.2007.12.026","article-title":"The metabolic profile of early Huntington&apos;s disease\u2014a combined human and transgenic mouse study","volume":"210","author":"AO Goodman","year":"2008","journal-title":"Exp Neurol"},{"issue":"8","key":"ref35","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S1474-4422(09)70178-4","article-title":"Beyond the brain: widespread pathology in Huntington&apos;s disease","volume":"8","author":"JM van der Burg","year":"2009","journal-title":"Lancet Neurol"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3233\/JHD-160189","article-title":"Delayed onset and reduced cognitive deficits through pre-cconditioning with 3-nitropropionic acid is dependent on sex and CAG repeat length in the <italic>R6\/2<\/italic> mouse model of Huntington&apos;s disease","volume":"5","author":"EA Skillings","year":"2016","journal-title":"J Huntington\u2019s Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/hmg\/ddi147","article-title":"Loss of wild-type huntingtin influences motor dysfunction and survival in the YAC128 mouse model of Huntington disease","volume":"14","author":"JM Van Raamsdonk","year":"2005","journal-title":"Hum Mol Gen"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbr.2006.12.004","article-title":"Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington&apos;s disease","volume":"178","author":"JL Dorner","year":"2007","journal-title":"Beh Brain Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"16027","DOI":"10.1074\/jbc.M710606200","article-title":"Sex-dependent effect of BAG1 in ameliorating motor deficits of Huntington disease transgenic mice","volume":"283","author":"AL Orr","year":"2008","journal-title":"J Biol Chem"},{"issue":"2","key":"ref40","doi-asserted-by":"crossref","first-page":"e9077","DOI":"10.1371\/journal.pone.0009077","article-title":"Responses to environmental enrichment differ with sex and genotype in a transgenic mouse model of Huntington&apos;s disease","volume":"5","author":"NI Wood","year":"2010","journal-title":"PLoS One"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0194580","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T13:58:50Z","timestamp":1589032730000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0194580"}},"subtitle":[],"editor":[{"given":"Michael","family":"Bader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,4,9]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0194580","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,9]]}}}